Key result
Acquired QTc interval prolongation in Takotsubo syndrome was associated with lower long-term all-cause mortality compared to the absence of prolongation (23.3% vs 43.7%; P=0.02).
Why the study?
Clinical variables predicting long-term mortality and recurrence of Takotsubo syndrome remain incompletely understood, including the prognostic role of acquired QTc interval prolongation.
Does acquired QTc interval prolongation predict mortality in patients with Takotsubo syndrome?
Cohort (n=105)
Does acquired QTc interval prolongation predict mortality in patients with Takotsubo syndrome?
Absolute Event Rate: 23.3% vs 43.7%
p-value: p=0.02
Acquired QTc interval prolongation at admission is associated with lower in-hospital, 30-day, and long-term mortality in patients with Takotsubo syndrome.
Acquired QTc prolongation warrants no immediate clinical action in Takotsubo syndrome; leaves open its prognostic role pending prospective validation.
BACKGROUND: Clinical variables that predict long-term mortality and recurrence of Takotsubo syndrome (TTS) are not completely understood as the role of acquired corrected QT interval (QTc) prolongation. AIM: To detect the prevalence of QTc interval prolongation in patients with TTS and to evaluate its long-term prognostic impact. METHODS: QTc intervals were analysed in 105 patients presenting with symptoms of TTS. These patients were included in an ongoing retrospective cohort database. The cohort was subsequently subdivided into two groups based on the presence (long QT (LQT) group, n = 73, 69.52%) or absence (non-long QT (non-LQT) group, n = 32, 30.43%) of QTc interval prolongation. Patients were followed up over a mean period of 4.2 years. The rate of life-threatening arrhythmia during the first 30 days in the LQT group was comparable with the non-LQT group (10.9 vs 12.5%), whereas in-hospital mortality and 30-day mortality occurred less frequently in the LQT group (2.7 vs 18.75%, P < 0.01). RESULTS: During this time span, 17 (23.3%) patients with acquired LQT syndrome died, whereas 14 (43.7%) patients with non-LQT duration died. Kaplan-Meier survival rates were significantly higher in the LQT group than those in the non-LQT group (Log-rank-test, P = 0.02). On multivariate analysis, the QTc interval was an independent negative predictor of all-cause mortality (P = 0.02). CONCLUSION: The QTc interval at admission is an independent negative predictor of long-term adverse outcome in patients with TTS.
No takes yet. Share an insight, caveat, or question.
Hohneck et al. (2018) conducted a cohort in Takotsubo syndrome (n=105). QTc interval prolongation vs. Absence of QTc interval prolongation was evaluated on all-cause mortality (p=0.02). Acquired QTc interval prolongation in Takotsubo syndrome was associated with lower long-term all-cause mortality compared to the absence of prolongation (23.3% vs 43.7%; P=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: